Amgen Gives Update Regarding Drug Trials
March 17, 2015 at 10:38 AM EDT
RBC Capital Markets issued a report on Amgen, Inc. (NASDAQ: AMGN) after the company presented at the ACC conference. The firm ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.